Home > Newsletters > FDAnews Device Daily Bulletin > Industry Praises PMA Acceptance Draft Guidance, With Some Reservations
FDAnews Device Daily Bulletin
Sept. 28, 2012 | Vol. 9 No. 191
Industry Praises PMA Acceptance Draft Guidance, With Some Reservations
The FDA’s draft guidance on the PMA acceptance process follows transparency and time goals outlined during recent FDA-industry Medical Device User Fee Act (MDUFA) negotiations and provides details that will help ensure a smooth and productive review, industry comments suggest. The proposed guidance accurately reflects the spirit of the MDUFA commitment letter, wrote Johnson & Johnson (J&J) Vice President of Regulatory Affairs Minnie Baylor-Henry.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.